nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Analyzing survival data from clinical trials and observational studies
|
Crowley, John |
|
1996 |
17 |
4 |
p. 353-354 2 p. |
artikel |
2 |
An open letter to the FDA regarding changes in reporting procedures for drugs and biologies proposed in the wake of the FIAU tragedy
|
Meinert, Curtis L. |
|
1996 |
17 |
4 |
p. 273-284 12 p. |
artikel |
3 |
A note on conventional null hypothesis testing in active control equivalence studies
|
Hauschke, Dieter |
|
1996 |
17 |
4 |
p. 347-349 3 p. |
artikel |
4 |
A note on quantifying follow-up in studies of failure time
|
Schemper, Michael |
|
1996 |
17 |
4 |
p. 343-346 4 p. |
artikel |
5 |
Biological rationale and clinical experience with hyperthermia
|
Engin, Kayihan |
|
1996 |
17 |
4 |
p. 316-342 27 p. |
artikel |
6 |
Blinding during data analysis and writing of manuscripts
|
Gøtzsche, Peter C. |
|
1996 |
17 |
4 |
p. 285-290 6 p. |
artikel |
7 |
Clinical measurement in drug evaluation
|
Ellenberg, Susan S. |
|
1996 |
17 |
4 |
p. 354-355 2 p. |
artikel |
8 |
Comment
|
Knatterud, Genell L. |
|
1996 |
17 |
4 |
p. 290-292 3 p. |
artikel |
9 |
Discussion
|
Pocock, Stuart J. |
|
1996 |
17 |
4 |
p. 292-293 2 p. |
artikel |
10 |
Masking drug treatments in the Cardiac Arrhythmia Pilot Study (CAPS)
|
Haakenson, Clair |
|
1996 |
17 |
4 |
p. 294-303 10 p. |
artikel |
11 |
Reply
|
Ng, Tie-Hua |
|
1996 |
17 |
4 |
p. 349-350 2 p. |
artikel |
12 |
Reply
|
Kadane, Joseph B. |
|
1996 |
17 |
4 |
p. 352- 1 p. |
artikel |
13 |
The Economic Evaluation of the FIRST Study: Design of a prospective analysis alongside a multinational phase III clinical trial
|
Schulman, Kevin A. |
|
1996 |
17 |
4 |
p. 304-315 12 p. |
artikel |
14 |
Two cheers for Bayes
|
O'Rourke, Keith |
|
1996 |
17 |
4 |
p. 350-352 3 p. |
artikel |